{"entity":{"type":"insider","cik":"0001380895","url":"/insider/0001380895","json_url":"/insider/0001380895.json","name":"Intervac, L.L.C.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":146,"n_filings":18,"first":"2008-07-18","last":"2011-04-20","span_basis":"filed_date"},"name_variants":[{"name":"Intervac, L.L.C.","source":"filing","n_filings":18,"first_seen":"2008-07-18","last_seen":"2011-04-20"}],"transactions":[{"id":9062797,"accession":"0001209191-11-023607","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-023607","line_url":"/filing/0001209191-11-023607#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":23.3146,"price_display":"23.31","price_state":"stated","total_value":163202.2,"total_display":"163,202.20","shares_owned_after":6136794.0,"shares_owned_after_display":"6,136,794","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-18","filed_date":"2011-04-20","scope":"insider"},{"id":2436180,"accession":"0000929638-08-000654","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000929638-08-000654","line_url":"/filing/0000929638-08-000654#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21000.0,"shares_display":"21,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":315000.0,"total_display":"315,000.00","shares_owned_after":7681835.0,"shares_owned_after_display":"7,681,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-15","filed_date":"2008-10-16","scope":"insider"},{"id":2436173,"accession":"0000929638-08-000654","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000929638-08-000654","line_url":"/filing/0000929638-08-000654#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75100.0,"shares_display":"75,100","price_per_share":15.02,"price_display":"15.02","price_state":"stated","total_value":1128002.0,"total_display":"1,128,002.00","shares_owned_after":7702835.0,"shares_owned_after_display":"7,702,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-14","filed_date":"2008-10-16","scope":"insider"},{"id":3642017,"accession":"0000929638-08-000586","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000929638-08-000586","line_url":"/filing/0000929638-08-000586#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2200.0,"shares_display":"2,200","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":33000.0,"total_display":"33,000.00","shares_owned_after":7779635.0,"shares_owned_after_display":"7,779,635","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-29","filed_date":"2008-10-01","scope":"insider"},{"id":3642016,"accession":"0000929638-08-000586","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000929638-08-000586","line_url":"/filing/0000929638-08-000586#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1700.0,"shares_display":"1,700","price_per_share":15.17,"price_display":"15.17","price_state":"stated","total_value":25789.0,"total_display":"25,789.00","shares_owned_after":7777935.0,"shares_owned_after_display":"7,777,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-29","filed_date":"2008-10-01","scope":"insider"},{"id":2652206,"accession":"0000950120-08-000472","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950120-08-000472","line_url":"/filing/0000950120-08-000472#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6700.0,"shares_display":"6,700","price_per_share":14.02,"price_display":"14.02","price_state":"stated","total_value":93934.0,"total_display":"93,934.00","shares_owned_after":7781835.0,"shares_owned_after_display":"7,781,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-22","filed_date":"2008-09-24","scope":"insider"},{"id":2757485,"accession":"0000950120-08-000464","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950120-08-000464","line_url":"/filing/0000950120-08-000464#line-3","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7200.0,"shares_display":"7,200","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":100800.0,"total_display":"100,800.00","shares_owned_after":7790835.0,"shares_owned_after_display":"7,790,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-19","filed_date":"2008-09-22","scope":"insider"},{"id":2757483,"accession":"0000950120-08-000464","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950120-08-000464","line_url":"/filing/0000950120-08-000464#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":14.03,"price_display":"14.03","price_state":"stated","total_value":32269.0,"total_display":"32,269.00","shares_owned_after":7788535.0,"shares_owned_after_display":"7,788,535","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-19","filed_date":"2008-09-22","scope":"insider"},{"id":2757477,"accession":"0000950120-08-000464","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950120-08-000464","line_url":"/filing/0000950120-08-000464#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":4200.0,"total_display":"4,200.00","shares_owned_after":7798035.0,"shares_owned_after_display":"7,798,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-18","filed_date":"2008-09-22","scope":"insider"},{"id":3795104,"accession":"0000950120-08-000460","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000950120-08-000460","line_url":"/filing/0000950120-08-000460#line-11","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":14.16,"price_display":"14.16","price_state":"stated","total_value":7080.0,"total_display":"7,080.00","shares_owned_after":7798935.0,"shares_owned_after_display":"7,798,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-16","filed_date":"2008-09-17","scope":"insider"},{"id":3795103,"accession":"0000950120-08-000460","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000950120-08-000460","line_url":"/filing/0000950120-08-000460#line-10","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":14.19,"price_display":"14.19","price_state":"stated","total_value":5676.0,"total_display":"5,676.00","shares_owned_after":7798535.0,"shares_owned_after_display":"7,798,535","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-16","filed_date":"2008-09-17","scope":"insider"},{"id":3795101,"accession":"0000950120-08-000460","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000950120-08-000460","line_url":"/filing/0000950120-08-000460#line-9","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250.0,"shares_display":"250","price_per_share":14.06,"price_display":"14.06","price_state":"stated","total_value":3515.0,"total_display":"3,515.00","shares_owned_after":7799735.0,"shares_owned_after_display":"7,799,735","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-16","filed_date":"2008-09-17","scope":"insider"},{"id":3795099,"accession":"0000950120-08-000460","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000950120-08-000460","line_url":"/filing/0000950120-08-000460#line-8","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":14.2,"price_display":"14.20","price_state":"stated","total_value":2840.0,"total_display":"2,840.00","shares_owned_after":7798335.0,"shares_owned_after_display":"7,798,335","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-16","filed_date":"2008-09-17","scope":"insider"},{"id":3795097,"accession":"0000950120-08-000460","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000950120-08-000460","line_url":"/filing/0000950120-08-000460#line-7","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":14.08,"price_display":"14.08","price_state":"stated","total_value":2816.0,"total_display":"2,816.00","shares_owned_after":7799435.0,"shares_owned_after_display":"7,799,435","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-16","filed_date":"2008-09-17","scope":"insider"},{"id":3795096,"accession":"0000950120-08-000460","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000950120-08-000460","line_url":"/filing/0000950120-08-000460#line-6","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":14.075,"price_display":"14.08","price_state":"stated","total_value":1407.5,"total_display":"1,407.50","shares_owned_after":7799635.0,"shares_owned_after_display":"7,799,635","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-16","filed_date":"2008-09-17","scope":"insider"},{"id":3795094,"accession":"0000950120-08-000460","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950120-08-000460","line_url":"/filing/0000950120-08-000460#line-5","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":14.05,"price_display":"14.05","price_state":"stated","total_value":1405.0,"total_display":"1,405.00","shares_owned_after":7799985.0,"shares_owned_after_display":"7,799,985","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-16","filed_date":"2008-09-17","scope":"insider"},{"id":3795092,"accession":"0000950120-08-000460","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950120-08-000460","line_url":"/filing/0000950120-08-000460#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":14.04,"price_display":"14.04","price_state":"stated","total_value":1404.0,"total_display":"1,404.00","shares_owned_after":7800085.0,"shares_owned_after_display":"7,800,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-16","filed_date":"2008-09-17","scope":"insider"},{"id":3795090,"accession":"0000950120-08-000460","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950120-08-000460","line_url":"/filing/0000950120-08-000460#line-3","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":14.01,"price_display":"14.01","price_state":"stated","total_value":1401.0,"total_display":"1,401.00","shares_owned_after":7800235.0,"shares_owned_after_display":"7,800,235","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-16","filed_date":"2008-09-17","scope":"insider"},{"id":3795088,"accession":"0000950120-08-000460","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950120-08-000460","line_url":"/filing/0000950120-08-000460#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":1400.0,"total_display":"1,400.00","shares_owned_after":7800335.0,"shares_owned_after_display":"7,800,335","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-16","filed_date":"2008-09-17","scope":"insider"},{"id":3795085,"accession":"0000950120-08-000460","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950120-08-000460","line_url":"/filing/0000950120-08-000460#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50.0,"shares_display":"50","price_per_share":14.02,"price_display":"14.02","price_state":"stated","total_value":701.0,"total_display":"701.00","shares_owned_after":7800185.0,"shares_owned_after_display":"7,800,185","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-16","filed_date":"2008-09-17","scope":"insider"},{"id":3795083,"accession":"0000950120-08-000444","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000950120-08-000444","line_url":"/filing/0000950120-08-000444#line-6","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":676.0,"shares_display":"676","price_per_share":14.06,"price_display":"14.06","price_state":"stated","total_value":9504.56,"total_display":"9,504.56","shares_owned_after":7801059.0,"shares_owned_after_display":"7,801,059","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-10","scope":"insider"},{"id":3795081,"accession":"0000950120-08-000444","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950120-08-000444","line_url":"/filing/0000950120-08-000444#line-5","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":14.07,"price_display":"14.07","price_state":"stated","total_value":2814.0,"total_display":"2,814.00","shares_owned_after":7801735.0,"shares_owned_after_display":"7,801,735","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-10","scope":"insider"},{"id":3795079,"accession":"0000950120-08-000444","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950120-08-000444","line_url":"/filing/0000950120-08-000444#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":14.03,"price_display":"14.03","price_state":"stated","total_value":2806.0,"total_display":"2,806.00","shares_owned_after":7800735.0,"shares_owned_after_display":"7,800,735","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-10","scope":"insider"},{"id":3795077,"accession":"0000950120-08-000444","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950120-08-000444","line_url":"/filing/0000950120-08-000444#line-3","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":2800.0,"total_display":"2,800.00","shares_owned_after":7800435.0,"shares_owned_after_display":"7,800,435","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-10","scope":"insider"},{"id":3795075,"accession":"0000950120-08-000444","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950120-08-000444","line_url":"/filing/0000950120-08-000444#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":124.0,"shares_display":"124","price_per_share":14.04,"price_display":"14.04","price_state":"stated","total_value":1740.96,"total_display":"1,740.96","shares_owned_after":7800935.0,"shares_owned_after_display":"7,800,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-10","scope":"insider"},{"id":3795073,"accession":"0000950120-08-000444","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950120-08-000444","line_url":"/filing/0000950120-08-000444#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":14.01,"price_display":"14.01","price_state":"stated","total_value":1401.0,"total_display":"1,401.00","shares_owned_after":7800635.0,"shares_owned_after_display":"7,800,635","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-10","scope":"insider"},{"id":3248242,"accession":"0000950120-08-000431","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950120-08-000431","line_url":"/filing/0000950120-08-000431#line-5","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":9800.0,"total_display":"9,800.00","shares_owned_after":7802735.0,"shares_owned_after_display":"7,802,735","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-04","filed_date":"2008-09-08","scope":"insider"},{"id":3248236,"accession":"0000950120-08-000431","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950120-08-000431","line_url":"/filing/0000950120-08-000431#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":14.04,"price_display":"14.04","price_state":"stated","total_value":4212.0,"total_display":"4,212.00","shares_owned_after":7802035.0,"shares_owned_after_display":"7,802,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-04","filed_date":"2008-09-08","scope":"insider"},{"id":3248222,"accession":"0000950120-08-000431","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950120-08-000431","line_url":"/filing/0000950120-08-000431#line-3","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":14.01,"price_display":"14.01","price_state":"stated","total_value":4203.0,"total_display":"4,203.00","shares_owned_after":7802435.0,"shares_owned_after_display":"7,802,435","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-04","filed_date":"2008-09-08","scope":"insider"},{"id":3248213,"accession":"0000950120-08-000431","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950120-08-000431","line_url":"/filing/0000950120-08-000431#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":14.0425,"price_display":"14.04","price_state":"stated","total_value":1404.25,"total_display":"1,404.25","shares_owned_after":7801935.0,"shares_owned_after_display":"7,801,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-04","filed_date":"2008-09-08","scope":"insider"},{"id":3248205,"accession":"0000950120-08-000431","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950120-08-000431","line_url":"/filing/0000950120-08-000431#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":14.02,"price_display":"14.02","price_state":"stated","total_value":1402.0,"total_display":"1,402.00","shares_owned_after":7802335.0,"shares_owned_after_display":"7,802,335","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-04","filed_date":"2008-09-08","scope":"insider"},{"id":2757474,"accession":"0000950120-08-000419","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950120-08-000419","line_url":"/filing/0000950120-08-000419#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":8400.0,"total_display":"8,400.00","shares_owned_after":7803435.0,"shares_owned_after_display":"7,803,435","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-02","filed_date":"2008-09-04","scope":"insider"},{"id":3590228,"accession":"0000950120-08-000415","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000950120-08-000415","line_url":"/filing/0000950120-08-000415#line-14","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5300.0,"shares_display":"5,300","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":74200.0,"total_display":"74,200.00","shares_owned_after":7806735.0,"shares_owned_after_display":"7,806,735","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-29","filed_date":"2008-09-02","scope":"insider"},{"id":3590227,"accession":"0000950120-08-000415","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0000950120-08-000415","line_url":"/filing/0000950120-08-000415#line-13","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":14.01,"price_display":"14.01","price_state":"stated","total_value":9807.0,"total_display":"9,807.00","shares_owned_after":7805235.0,"shares_owned_after_display":"7,805,235","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-29","filed_date":"2008-09-02","scope":"insider"},{"id":3590226,"accession":"0000950120-08-000415","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000950120-08-000415","line_url":"/filing/0000950120-08-000415#line-12","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":14.33,"price_display":"14.33","price_state":"stated","total_value":8598.0,"total_display":"8,598.00","shares_owned_after":7804035.0,"shares_owned_after_display":"7,804,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-29","filed_date":"2008-09-02","scope":"insider"},{"id":3590225,"accession":"0000950120-08-000415","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000950120-08-000415","line_url":"/filing/0000950120-08-000415#line-11","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":14.005,"price_display":"14.00","price_state":"stated","total_value":8403.0,"total_display":"8,403.00","shares_owned_after":7806135.0,"shares_owned_after_display":"7,806,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-29","filed_date":"2008-09-02","scope":"insider"},{"id":3590224,"accession":"0000950120-08-000415","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000950120-08-000415","line_url":"/filing/0000950120-08-000415#line-10","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":14.02,"price_display":"14.02","price_state":"stated","total_value":4206.0,"total_display":"4,206.00","shares_owned_after":7804635.0,"shares_owned_after_display":"7,804,635","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-29","filed_date":"2008-09-02","scope":"insider"},{"id":3590223,"accession":"0000950120-08-000415","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000950120-08-000415","line_url":"/filing/0000950120-08-000415#line-9","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":14.015,"price_display":"14.02","price_state":"stated","total_value":4204.5,"total_display":"4,204.50","shares_owned_after":7804935.0,"shares_owned_after_display":"7,804,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-29","filed_date":"2008-09-02","scope":"insider"},{"id":3590222,"accession":"0000950120-08-000415","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000950120-08-000415","line_url":"/filing/0000950120-08-000415#line-8","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":14.0075,"price_display":"14.01","price_state":"stated","total_value":2801.5,"total_display":"2,801.50","shares_owned_after":7805935.0,"shares_owned_after_display":"7,805,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-29","filed_date":"2008-09-02","scope":"insider"},{"id":3590221,"accession":"0000950120-08-000415","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000950120-08-000415","line_url":"/filing/0000950120-08-000415#line-7","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11100.0,"shares_display":"11,100","price_per_share":14.37,"price_display":"14.37","price_state":"stated","total_value":159507.0,"total_display":"159,507.00","shares_owned_after":7812535.0,"shares_owned_after_display":"7,812,535","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-28","filed_date":"2008-09-02","scope":"insider"},{"id":3590220,"accession":"0000950120-08-000415","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000950120-08-000415","line_url":"/filing/0000950120-08-000415#line-6","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":14.35,"price_display":"14.35","price_state":"stated","total_value":11480.0,"total_display":"11,480.00","shares_owned_after":7823735.0,"shares_owned_after_display":"7,823,735","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-28","filed_date":"2008-09-02","scope":"insider"},{"id":3590219,"accession":"0000950120-08-000415","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950120-08-000415","line_url":"/filing/0000950120-08-000415#line-5","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":14.33,"price_display":"14.33","price_state":"stated","total_value":8598.0,"total_display":"8,598.00","shares_owned_after":7825035.0,"shares_owned_after_display":"7,825,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-28","filed_date":"2008-09-02","scope":"insider"},{"id":3590218,"accession":"0000950120-08-000415","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950120-08-000415","line_url":"/filing/0000950120-08-000415#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":14.38,"price_display":"14.38","price_state":"stated","total_value":7190.0,"total_display":"7,190.00","shares_owned_after":7812035.0,"shares_owned_after_display":"7,812,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-28","filed_date":"2008-09-02","scope":"insider"},{"id":3590217,"accession":"0000950120-08-000415","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950120-08-000415","line_url":"/filing/0000950120-08-000415#line-3","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":14.34,"price_display":"14.34","price_state":"stated","total_value":7170.0,"total_display":"7,170.00","shares_owned_after":7824535.0,"shares_owned_after_display":"7,824,535","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-28","filed_date":"2008-09-02","scope":"insider"},{"id":3590216,"accession":"0000950120-08-000415","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950120-08-000415","line_url":"/filing/0000950120-08-000415#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":14.355,"price_display":"14.36","price_state":"stated","total_value":1435.5,"total_display":"1,435.50","shares_owned_after":7823635.0,"shares_owned_after_display":"7,823,635","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-28","filed_date":"2008-09-02","scope":"insider"},{"id":3590215,"accession":"0000950120-08-000415","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950120-08-000415","line_url":"/filing/0000950120-08-000415#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":14.305,"price_display":"14.30","price_state":"stated","total_value":1430.5,"total_display":"1,430.50","shares_owned_after":7825635.0,"shares_owned_after_display":"7,825,635","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-28","filed_date":"2008-09-02","scope":"insider"},{"id":2652203,"accession":"0000950120-08-000413","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0000950120-08-000413","line_url":"/filing/0000950120-08-000413#line-30","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":112000.0,"total_display":"112,000.00","shares_owned_after":7843735.0,"shares_owned_after_display":"7,843,735","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-28","filed_date":"2008-09-02","scope":"insider"},{"id":2652200,"accession":"0000950120-08-000413","txn_seq":29,"anchor":"line-29","filing_url":"/filing/0000950120-08-000413","line_url":"/filing/0000950120-08-000413#line-29","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3700.0,"shares_display":"3,700","price_per_share":14.06,"price_display":"14.06","price_state":"stated","total_value":52022.0,"total_display":"52,022.00","shares_owned_after":7837935.0,"shares_owned_after_display":"7,837,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-28","filed_date":"2008-09-02","scope":"insider"},{"id":2652196,"accession":"0000950120-08-000413","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0000950120-08-000413","line_url":"/filing/0000950120-08-000413#line-28","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2050.0,"shares_display":"2,050","price_per_share":14.24,"price_display":"14.24","price_state":"stated","total_value":29192.0,"total_display":"29,192.00","shares_owned_after":7827135.0,"shares_owned_after_display":"7,827,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-28","filed_date":"2008-09-02","scope":"insider"},{"id":2652192,"accession":"0000950120-08-000413","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0000950120-08-000413","line_url":"/filing/0000950120-08-000413#line-27","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380895","owner_name":"Intervac, L.L.C.","owner_url":"/insider/0001380895","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1700.0,"shares_display":"1,700","price_per_share":14.07,"price_display":"14.07","price_state":"stated","total_value":23919.0,"total_display":"23,919.00","shares_owned_after":7836235.0,"shares_owned_after_display":"7,836,235","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-28","filed_date":"2008-09-02","scope":"insider"}],"next_cursor":"2008-08-28|2652192","ledger_fault":false,"count":{"value":146,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":146,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":146},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001367644","name":"Emergent BioSolutions Inc.","url":"/issuer/0001367644","role":"Ten percent owner","n_filings":18,"first_seen":"2008-07-18","last_seen":"2011-04-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001380895","retrieved_at":"2026-08-21T03:45:48+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}